Fig. 3From: Midazolam exhibits antitumour and enhances the efficiency of Anti-PD-1 immunotherapy in hepatocellular carcinomaMDZ downregulated PD-L1 expression in HCC cells through the NF-κB pathway. (A) The protein expression levels of PD-L1, P65, and p-P65 in HCC cells after MDZ treatment. B, C The panels show the protein band grey values. ***P < 0.001, ****P < 0.0001Back to article page